Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Researchers' work from University of Kentucky focuses on cancer gene therapy
September 2nd, 2008
Researchers detail in 'MAZ drives tumor-specific expression of PPAR gamma 1 in breast cancer cells,' new data in cancer gene therapy. According to recent research from the United States, "The peroxisome proliferator-activated receptor gamma 1 (PPARgamma1) is a nuclear receptor that plays a pivotal role in breast cancer and is highly over-expressed relative to normal epithelia. We have previously reported that the expression of PPARgamma1 is mediated by at least six distinct promoters and expression in breast cancer is driven by a tumor-specific promoter (pA1)." "Deletional analysis of this promoter fragment revealed that the GC-rich, 263 bp sequence proximal to the...
Source: Cancer Weekly (2008-09-02)
|
